China's top scientist, who developed the first inactivated COVID-19 vaccine at the height of the pandemic in the country in 2020, has been dismissed from Parliament for alleged corruption. Yang Xiaoming, the chairman of China National Pharmaceutical Group's vaccine subsidiary China National Biotec Group (CNBG), has been stripped of his membership in the National People's Congress (NPC) due to serious discipline and law violations, official media reported here on Monday. The charge of serious discipline and law violations is a common euphemism for corruption under the ruling Communist Party of China (CPC) disciplinary practice. Yang, 62, is a veteran researcher who headed the CNBG - a vaccine subsidiary of state-owned Sinopharm - and led a team that developed Sinopharm's BBIBP-CorV vaccine, China's first coronavirus shot approved for general use. Coronavirus first surfaced in the Chinese city of Wuhan in March 2020 and later spread to the world, becoming the pandemic of the century
Covid-19 was the leading cause of death in India, as per the study. The age-standardised rate of deaths for both males and females was 156.8 per 100,000 population
India's score on the Global Health Security Index declined from 43.6 in 2019 to 42.8 in 2021. The country's score was lower than others. Japan, Brazil and Russia, meanwhile, recorded an improvement
JN.1, a new COVID variant, has become dominant in China. A total of 6,653 cases were reported last month
A high proportion of COVID-19 infections in the general population lead to persistent infections lasting a month or more, according to a study. It has long been thought that prolonged COVID-19 infections in immunocompromised individuals may have been the source of the multiple new variants that arose during the pandemic and seeded successive waves of infection, the researchers said. However, until now, the prevalence of persistentS-CoV-2 infections in the general population and how the virus evolves in these situations remained unknown, they said. The study, published in the journal Nature, used data from the UK Office for National Statistics COVID-19 Infection Survey (ONS-CIS), which tested participants monthly. Of the over 90,000 participants, 3,603 provided two or more Covid positive samples between November 2020 and August 2022. Of these, 381 individuals tested positive for the same variant over a period of a month or longer. Within this group, 54 individuals had a persistent .
Researchers have examined a man in Germany who claims to have received 217 vaccinations against COVID-19 and found that his immune system was fully functional. Until now, it has been unclear what effects hypervaccination such as this would have on the immune system. Some scientists were of the opinion that immune cells would become less effective after becoming used to the antigens. However, the case study published in The Lancet Infectious Diseases journal found that the immune system of the person is fully functional. More than 60 million people in Germany have been vaccinated againstS-CoV-2, a majority of them several times, the researchers said. The man examined by a team at FriedrichAlexander University ErlangenNurnberg (FAU) in Germany claims to have received 217 vaccinations for private reasons. There is official confirmation for 134 of these vaccinations, they said. "We learned about his case via newspaper articles," said Kilian Schober from FAU. "We then contacted him an
India has logged 110 new cases of Covid, while the number of active cases of the infection stood at 893, according to the Union Health Ministry data updated on Monday. No new deaths have been reported in a span of 24 hours, the data updated at 8 am stated. The number of daily cases had dropped to double-digits till December 5, 2023 but cases had begun to increase after emergence of a new variant and cold weather conditions. After December 5, a maximum of 841 new cases were reported on December 31, 2023 which is 0.2 per cent of the peak cases reported in May 2021. India has witnessed three waves of COVID-19 in the past with the peak incidence of daily new cases and deaths being reported during the Delta wave in April-June 2021. At its peak, 4,14,188 new cases and 3,915 deaths were reported on May 7, 2021. Since the pandemic began in early 2020, more than 4.5 crore people have been infected and over 5.3 lakh deaths recorded.
India has recorded 188 new cases of Covid, while the number of active cases of the infection stood at 1,473, the health ministry said on Sunday. No deaths have been reported in a span of 24 hours, according to the ministry's data updated at 8 am. The number of daily cases had dropped to double-digits till December 5, 2023 but cases had begun to increase after emergence of a new variant and cold weather conditions. After December 5, 2023 a maximum of 841 new cases were reported on December 31, 2023 which was 0.2 per cent of the peak cases reported in May 2021, official sources said. "The currently available data suggests that the JN.1 variant is neither leading to an exponential rise in new cases nor a surge in hospitalisation and mortality," the sources stated. India has witnessed three waves of COVID-19 in the past with the peak incidence of daily new cases and deaths being reported during the Delta wave in April-June 2021. At its peak, 414,188 new cases and 3,915 deaths were ..
The INSACOG on Monday said 2,083 cases of COVID-19 sub-variant JN.1 and its lineages have been detected in the country so far. There are 814 SARS-CoV-2 sequences of JN.1 across 18 states and UTs while its sub-lineage JN.1.1 has been detected in 943 cases, according to the data compiled by the Indian SARS-CoV-2 Genomics Consortium (INSACOG). JN.1.11 has been detected in 244 cases while the rest of the cases were detected in the sub-lineages of JN.1. Last month, the Centre asked the states and Union Territories to maintain a constant vigil amid detection of new variants in the country. The World Health Organisation has classified JN.1 as a separate "variant of interest" given its rapidly-increasing spread, but said it poses a "low" global public health risk. The JN.1 sub-variant of the coronavirus was previously classified as a variant of interest (VOI) as part of the BA.2.86 sub-lineages, the parent lineage that is classified as a VOI, the world body said.
India saw a single-day rise of 187 coronavirus cases, while the number of active infections was recorded at 1,674, the health ministry said on Friday. One new death from Maharashtra has been reported in a span of 24 hours, according to the ministry's data updated at 8 am. The number of daily cases had dropped to double digits till December 5, but cases began to increase after emergence of a new variant and cold weather conditions. After December 5, the highest single-day rise of 841 new cases was reported on December 31, 2023, which is 0.2 per cent of the peak cases reported in May 2021, official sources said. Of the total active cases, a large majority of these (around 92 per cent) are recovering under home isolation. "The currently available data suggests that the JN.1 variant is neither leading to an exponential rise in the new cases nor a surge in the hospitalisation and mortality," an official source stated. India has witnessed three waves of COVID-19 in the past with the p
WHO director-general warns that the future pandemic could be deadlier. Here's what Tedros Ghebreyesus said at the World Economic Forum
India saw a single-day rise of 269 new cases of COVID-19, while the number of active cases of the infection has declined to 2,556, the health ministry said on Wednesday. Three deaths two from Kerala and one from Maharashtra have been reported in the last 24 hours, according to the ministry's data updated at 8 am. The number of daily cases had dropped to double-digits till December 5, but cases began to increase after the emergence of a new variant and cold weather conditions. After December 5, a maximum of a single-day rise of 841 new cases was reported on December 31, 2023, which is 0.2 per cent of the peak cases reported in May 2021, official sources said. Of the total active cases, around 92 per cent are recovering under home isolation. "The currently available data suggests that the JN.1 sub-variant is neither leading to an exponential rise in the new cases nor a surge in the hospitalisation and mortality," the official source stated. India has witnessed three waves of COVI
India's first indigenously developed COVID-19 vaccine, Corbevax, has been granted an Emergency Use Listing by the World Health Organisation, the company which manufactures it in India said here on Tuesday. Corbevax is based on a protein sub-unit platform and manufactured by the pharmaceutical firm Biological E Limited in India. Mahima Datla, Managing Director of Biological E Ltd said: We are pleased with the WHO Emergency Use Listing (EUL) because it would help us use the platform to continue developing COVID-19 vaccines as and when it starts impacting public health. We are confident that this endorsement from WHO will bolster our global fight against COVID-19.'' The Drugs Controller General of India (DCGI) had already approved Corbevax for restricted use in emergency among adults, adolescents and young children in a sequential manner from December 2021 to April 2022. It was also given approval for use as India's first heterologous COVID-19 booster shot for adults aged 18 and above
A total of 1,200 cases of COVID-19 sub-variant JN.1 have been reported in the country so far with Nagaland becoming the latest of the 17 states and Union territories to have detected its presence, according to INSACOG on Saturday. Data compiled by the Indian SARS-CoV-2 Genomics Consortium (INSACOG) showed Karnataka has reported the highest number of JN.1 cases at 215, followed by Andhra Pradesh (189), Maharashtra (170), Kerala (154), West Bengal (96), Goa (90), Tamil Nadu (88) and Gujarat (76). Telangana and Rajasthan have recorded 32 JN.1 cases each, Chhattisgarh has recorded 25, Delhi 16, Uttar Pradesh 7, Haryana five, Odisha three, and Uttarakhand and Nagaland one each, according to the data accessed by PTI. The Centre has asked the states and Union territories to maintain a constant vigil amid an uptick in the number of Covid cases and the detection of the JN.1 sub-variant in the country. The states have been urged to ensure effective compliance of the detailed operational ...
The number of cases of COVID-19 sub-variant JN.1 has crossed 1,000 mark with Uttar Pradesh becoming the latest state to join the list of 16 states and UTs which have detected its presence, according to INSACOG. The data compiled by the Indian SARS-CoV-2 Genomics Consortium (INSACOG) showed Karnataka has reported the highest number of cases at 214, followed by Maharashtra (170), Kerala (154), Andhra Pradesh (189), Gujarat (76) and Goa (66). Telangana and Rajasthan have recorded 32 JN.1 cases each, Chhattisgarh has recorded 25, Tamil Nadu 22, Delhi 16, Uttar Pradesh 6, Haryana five, Odisha three, West Bengal two and Uttarakhand one, according to the data. A total of 1,013 cases of JN.1 have been detected till now across the 16 states and UTs. The Centre has asked the states and Union territories to maintain a constant vigil amid an uptick in the number of Covid cases and the detection of the JN.1 sub-variant in the country. The states have been urged to ensure effective compliance o
COVID-19 sub-variant JN.1 has spread to 15 states and Union territories with a total of 923 cases of the infection reported so far, according to the INSACOG. Data compiled by the Indian SARS-CoV-2 Genomics Consortium (INSACOG) showed Karnataka has reported the highest number of cases at 214, followed by Maharashtra (170), Kerala (154), Andhra Pradesh (105), Gujarat (76) and Goa (66). Telangana and Rajasthan have recorded 32 JN.1 cases each, Chhattisgarh has recorded 25, Tamil Nadu 22, Delhi 16, Haryana five, Odisha three, West Bengal two and Uttarakhand one. Even though the number of cases is rising and the JN.1 sub-variant has been detected in the country, there is no cause of immediate concern as the majority of those infected are opting for home-based treatment, indicating a mild illness, officials said. The Centre has asked the states and Union territories to maintain a constant vigil amid an uptick in the number of Covid cases and the detection of the JN.1 sub-variant in the .
India recorded 514 new cases of COVID-19, while the number of active cases of the infection has declined to 3,422, the health ministry said on Thursday. Three deaths two in Maharashtra and one in Karnataka have been reported in a span of 24 hours, according to the ministry's data updated at 8 am. The number of daily cases had dropped to double-digits till December 5, 2023, but cases began to increase after the emergence of a new sub-variant -- JN.1 -- and cold weather conditions. After December 5, a maximum of a single-day rise of 841 new cases was reported on December 31, 2023, which is 0.2 per cent of the peak cases reported in May 2021, official sources said. Of the total active cases, around 92 per cent are recovering under home isolation. "The currently available data suggests that the JN.1 sub-variant is neither leading to an exponential rise in the new cases nor a surge in the hospitalisation and mortality," the official source stated. India has witnessed three waves of
The head of the U.N. health agency said Wednesday holiday gatherings and the spread of the most prominent variant globally led to increased transmission of COVID-19 last month. Tedros Adhanom Ghebreyesus said nearly 10,000 deaths were reported in December, while hospital admissions during the month jumped 42% in nearly 50 countries mostly in Europe and the Americas that shared such trend information. "Although 10,000 deaths a month is far less than the peak of the pandemic, this level of preventable deaths is not acceptable," the World Health Organization director-general told reporters from its headquarters in Geneva. He said it was certain that cases were on the rise in other places that haven't been reporting, calling on governments to keep up surveillance and provide continued access to treatments and vaccines. Tedros said the JN.1 variant was now the most prominent in the world. It is an omicron variant, so current vaccines should still provide some protection. Maria Van ..
People following a largely plant-based or vegetarian diet are 39 per cent less likely to get infected with Covid, new research has found. Researchers found that omnivores consuming meat more than three times a week reported a "significantly higher" incidence of COVID-19 than those dependent on plant-based or vegetarian diets. They were also more likely to have had moderate to severe infection, the study published in the "British Medical Journal Nutrition Prevention & Health" has found. The researchers, including those from the Universidade de Sao Paulo, Brazil, said it may be that plant-based diets provide more nutrients that boost the immune system and help fight viral infections The findings suggest that a diet high in vegetables, legumes and nuts, and low in dairy and meat products may thus help ward off the infection, they said. However, being an observational study, the team could not establish a causal relationship. They also acknowledged that, having relied on personal ...
A total of 819 cases of COVID-19 sub-variant JN.1 were reported from 12 states till Monday, official sources said. They said 250 cases were reported from Maharashtra, 199 from Karnataka, 148 from Kerala, 49 from Goa, 36 from Gujarat, 30 each from Andhra Pradesh and Rajasthan, 26 each from Tamil Nadu and Telangana, 21 from Delhi, three from Odisha and one from Haryana. Even though the number of JN.1 cases is rising, there is no cause of immediate concern as the majority of those infected are opting for home-based treatment, indicating a mild illness, officials said. The Centre has asked the states and Union territories to maintain a constant vigil amid an uptick in the number of Covid cases and the detection of the JN.1 sub-variant of the virus in the country. The states have been urged to ensure effective compliance of the detailed operational guidelines for the revised Covid surveillance strategy shared with them by the Union Ministry of Health and Family Welfare. The states have